Translational Pipelines
Translational Pipelines: Invited Panel on Funding Evidence-Based mHealth Technologies
Tuesday, December 4 - 3:30 - 4:45 PM
Session Overview
This invited research session of innovators, public and private sector investors, and academic thought leaders will discuss translational pathways for commercializing evidence-based mHealth technologies. Topics include how the National Cancer Institute (NCI) Small Business Innovation Research (SBIR) programs fund such technologies, what the venture capital community is looking for, the experiences of developers building and evaluating products, and the future of mHealth.
Speakers
|
Abdul Shaikh Program Director NCI |
Gary Bennett Associate Professor Duke University |
Chris Bergstrom Chief Strategy Officer WellDoc |
Anne DeGheest Managing Director & Founder MedStars |
|
Barbara Rapchak CEO Leap of Faith Technologies |
Patricia Weber Program Director NCI |
